hypothyroidism: Abnormally low levels of thyroid hormone.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
233 |
4. Check minimum number of eventsNone |
233 |
5. Include endpointsNone |
233 |
6. Filter based on genotype QC (FinnGen only) |
200 |
Control definitions (FinnGen only)
- Control exclude
- E4_THYROID
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E03
- Name in latin
- Hypothyreosis postinfectiosa
Similar endpoints
↥List of similar endpoints to
Postinfectious hypothyroidism
based on the number of shared cases.
Similar with more cases:
- Hypothyroidism (congenital or acquired)
- Hypothyreosis and Thyroxine purchase for inclusion criteria
- Disorders of the thyroid gland
- Used for control exclusion in common control thyroid runs
- Endocrine, nutritional and metabolic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2062 | 1681 | 349 |
| Only index persons | 1434 | 1198 | 236 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.01 |
| Only index persons | 0.04 | 0.04 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 55.61 | 56.08 | 52.28 |
| Only index persons | 48.62 | 49.33 | 45.03 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 200 | 165 | 35 |
| Unadjusted period prevalence (%) | 0.05 | 0.06 | 0.02 |
| Median age at first event (years) | 41.77 | 40.41 | 48.20 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 208
- Matched controls
- 2080
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H03AA01
ATC
levothyroxine sodium; systemic
2048.7
245.8
201
28
104
Kela drug reimbursment
Thyroid insufficiency
1923.6
185.7
153
*
2448A
ICD-9 Finland
Acquired hypothyroidism, Other specified acquired hypothyroidism[HYPOTHYREOSIS POST THYREOIDITIDEM]
+∞
171.5
140
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
577.5
157.2
138
7
E03.3
ICD-10 Finland
Postinfectious hypothyroidism
+∞
80.6
72
*
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
+∞
50.0
46
*
A10AA02, ,
ATC
18.2
45.4
39
26
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
17.7
43.6
38
26
E03
ICD-10 Finland
Other hypothyroidism
502.3
42.8
41
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
487.0
41.7
40
*
A10AB01
ATC
insulin (human); parenteral
15.9
40.2
37
28
A10AA01, ,
ATC
18.3
40.0
34
22
A10AB04
ATC
insulin lispro; parenteral
16.7
38.3
34
24
T89
ICPC
Diabetes insulin dependent
13.0
35.7
37
34
A10AC01
ATC
insulin (human); parenteral
7.8
31.2
50
81
T86
ICPC
Hypothyroidism/myxoedema
167.5
28.4
29
*
A10AB05
ATC
insulin aspart; parenteral
7.3
26.9
45
76
A10AE04
ATC
insulin glargine; parenteral
6.2
25.0
50
101
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
25.9
23.9
33
15
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
23.1
21.1
30
15
A10AE05
ATC
insulin detemir; parenteral
7.9
21.0
31
45
H04AA01
ATC
glucagon; nasal, parenteral
31.3
19.2
25
9
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
+∞
18.0
17
*
E10
ICD-10 Finland
Type 1 diabetes mellitus
69.3
17.0
19
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
15.6
15.5
25
18
103
Kela drug reimbursment
Diabetes, insulin-treated
3.3
14.9
83
351
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.2
13.9
76
315
E03.8
ICD-10 Finland
Other specified hypothyroidism
+∞
13.7
13
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
149.3
13.6
14
*
XCK10
NOMESCO Finland
Photography of fundus of eye
4.5
13.5
37
96
A10AE06
ATC
insulin degludec; parenteral
11.1
12.9
24
24
A10AD01
ATC
insulin (human); parenteral
14.6
12.2
20
15
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
10.2
11.8
23
25
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.5
10.7
42
140
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
24.9
10.4
14
6
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
42.3
10.1
12
*
K29.4
ICD-10 Finland
Chronic atrophic gastritis
12.2
9.8
17
15
H3603, E103,
ICD-10 Finland
57.8
9.7
11
*
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
57.8
9.7
11
*
SPAT1262
SPAT
Handing over of treatment supplies
3.0
9.3
48
188
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
38.5
9.1
11
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
8.7
117
727
J01FF01
ATC
clindamycin; systemic
2.5
8.6
69
340
B03BA03
ATC
hydroxocobalamin; parenteral
4.3
8.4
23
59
A12AA04
ATC
calcium carbonate; oral
23.1
8.1
11
5
A11CC03
ATC
alfacalcidol; systemic
11.4
7.9
14
13
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
7.8
53
239
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
7.6
77
418
24409
ICD-8 Finland
Myxoedema, (hypothyreosis) NUD
82.9
7.5
8
*
4019X
ICD-9 Finland
Essential hypertension, Unspecified
7.3
7.5
17
25
A10AA03, ,
ATC
16.5
7.3
11
7
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
12.6
7.2
12
10
A12BA01
ATC
potassium chloride; oral
4.4
7.0
18
44
107
Kela drug reimbursment
Pernicious anaemia
9.8
6.9
13
14
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
9.8
6.9
13
14
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
41.4
6.8
8
*
N06AA09
ATC
amitriptyline; systemic
3.0
6.7
31
113
H02AB04
ATC
methylprednisolone; systemic
2.6
6.6
42
182
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
10.5
6.6
12
12
T90
ICPC
Diabetes non-insulin dependent
2.3
6.5
59
302
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
72.0
6.5
7
*
C03DA01
ATC
spironolactone; oral
2.8
6.4
36
147
SPAT1263
SPAT
Sampling
2.1
6.3
96
604
E03.1
ICD-10 Finland
Congenital hypothyroidism without goitre
+∞
6.3
6
*
H03BB01
ATC
carbimazole; oral
27.6
6.3
8
*
CKC12
NOMESCO Finland
Photocoagulation of retina
4.4
6.2
16
39
OAB50, ,
SPAT
3.4
6.1
23
74
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.2
6.1
63
340
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
37
68
6.40
20.13
2.8
1.5
3.76
4.29
pmol/l
2.35
32
59
185
1372
4.15
10.68
11.7
2.8
16.55
14.54
pmol/l
14.29
176
1260
29
77
4.21
10.17
4.0
3.9
1.41
1.76
mmol/l
0.23
21
61
91
573
2.05
5.86
7.6
3.8
15.04
5.36
mg/mmol
1.02
60
339
55
286
2.25
5.80
1.7
1.7
1362.24
1309.06
nmol/l
0.08
50
219
126
900
2.01
5.61
11.8
5.8
1.21
1.22
mmol/l
1.00
110
786
114
801
1.94
5.17
10.2
5.1
1.21
1.22
mmol/l
0.87
105
746
137
1033
1.96
4.93
10.2
9.8
4.23
4.18
e9/l
0.09
127
910
117
843
1.89
4.78
3.3
2.4
76.00
77.92
nmol/l
0.31
107
768
64
379
1.99
4.72
2.1
1.8
1817.91
460.22
pmol/l
0.50
56
322
139
1063
1.93
4.68
7.3
4.2
7.84
6.57
mmol/l
4.93
131
1007
109
779
1.84
4.47
2.3
2.1
108.49
95.89
pmol/l
1.30
54
382
129
980
1.83
4.25
5.0
4.3
0.03
0.00
estimate
0.38
34
204
100
704
1.81
4.24
4.1
4.0
46.14
28.65
ng/l
0.50
67
489
130
996
1.81
4.10
5.1
4.3
0.00
0.02
estimate
0.68
31
192
129
990
1.80
4.01
5.0
4.3
0.00
0.00
estimate
-0.00
35
207
80
536
1.80
3.93
1.8
1.6
18.95
21.07
nmol/l
0.79
75
450
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
29
4.33
3.77
2.7
2.9
0.21
0.37
iu/ml
—
6
19
104
764
1.72
3.64
4.8
4.1
0.14
0.05
estimate
0.40
28
175
22
94
2.50
3.55
1.4
1.2
106.10
78.94
u/ml
0.17
13
31
9
18
5.17
3.41
1.6
1.1
—
—
—
0
0
186
1655
2.17
3.06
14.0
4.0
1.83
1.88
mu/l
0.05
176
1533
46
281
1.82
2.98
2.2
1.8
—
—
—
0
0
13
47
2.88
2.87
1.2
1.3
—
—
—
0
0
19
84
2.39
2.87
2.6
1.7
16.04
5.35
iu/ml
—
5
20
61
409
1.70
2.86
1.5
1.4
24.46
30.26
iu/ml
0.20
19
134
77
550
1.64
2.83
4.2
3.5
0.04
0.02
estimate
0.20
27
169
24
120
2.13
2.74
2.1
1.5
—
—
—
0
0
105
814
1.59
2.73
7.3
3.6
34.97
36.00
g/l
1.18
100
767
57
380
1.69
2.72
1.5
1.3
3.77
12.29
u/ml
1.58
25
144
35
202
1.88
2.70
6.1
5.0
35.92
32.40
%
0.98
26
129
62
424
1.66
2.68
1.5
1.3
0.73
1.89
u/ml
—
9
122
76
552
1.59
2.57
5.1
4.3
0.00
0.01
estimate
0.50
31
191
11
37
3.08
2.53
1.0
1.1
—
2.99
—
0
9
12
45
2.77
2.50
7.4
2.4
—
—
—
0
0
7
16
4.49
2.49
1.3
1.2
—
—
—
0
0
76
557
1.57
2.45
3.0
3.1
1768.64
1127.05
ng/l
0.48
67
479
158
1372
1.63
2.35
7.5
4.6
13.14
11.95
mm/h
0.58
147
1281
11
41
2.78
2.24
1.4
1.7
—
—
—
0
0
48
321
1.64
2.24
1.5
1.6
—
—
—
0
0
5
9
5.66
2.22
1.6
1.1
23.40
22.96
nmol/l
—
5
9
59
420
1.57
2.12
1.7
1.6
1.29
1.24
mg/l
0.03
47
344
21
111
1.99
2.10
6.5
5.5
25.18
24.96
mmol/l
0.08
21
111
7
20
3.58
2.07
1.1
1.1
—
—
—
0
0
14
64
2.27
1.99
3.0
1.9
—
—
—
0
0
9
33
2.80
1.95
2.4
2.0
8.46
8.45
pmol/l
—
9
33
6
16
3.83
1.95
1.7
1.4
—
—
—
0
0
22
122
1.90
1.93
8.8
2.6
141.92
76.86
ng/l
0.81
16
108
19
100
1.99
1.93
2.2
1.6
—
—
—
0
0
25
145
1.82
1.92
4.9
3.6
1.22
1.23
mmol/l
0.27
19
127
85
672
1.45
1.81
2.7
3.0
2.34
2.36
mmol/l
1.07
75
612
11
48
2.36
1.73
1.2
1.4
—
—
—
0
0
12
56
2.21
1.64
1.0
1.3
—
2.42
—
0
13
5
14
3.63
1.62
1.6
1.2
—
—
—
0
0
67
516
1.44
1.62
4.3
2.9
0.58
0.38
e6/l
0.26
52
369
10
43
2.39
1.61
1.3
1.4
—
—
—
0
0
7
26
2.75
1.59
1.3
1.2
—
—
—
0
0
6
20
3.06
1.59
1.0
1.5
—
—
—
0
0
6
20
3.06
1.59
1.5
1.1
—
—
—
0
0
189
1766
1.77
1.58
25.6
14.9
23.35
22.84
mg/l
0.07
170
1442
10
44
2.34
1.58
1.0
1.3
—
1.00
—
0
5
42
297
1.52
1.54
4.6
2.8
1.88
1.09
e6/l
0.31
26
152
30
196
1.62
1.54
2.1
1.8
—
—
—
0
0
58
441
1.44
1.49
2.6
2.2
334.78
326.17
umol/l
0.17
46
397
9
38
2.43
1.47
1.2
1.5
—
—
—
0
0
9
40
2.31
1.42
1.1
1.5
—
—
—
0
0
6
23
2.65
1.37
1.3
1.2
—
—
—
0
0
6
23
2.65
1.37
1.7
1.4
—
—
—
0
0
6
23
2.65
1.37
1.3
1.2
—
—
—
0
0
6
23
2.65
1.37
1.3
1.2
—
—
—
0
0
6
23
2.65
1.37
1.5
1.1
—
—
—
0
0
12
61
2.03
1.35
3.1
1.8
—
—
—
0
0
9
43
2.14
1.32
1.6
1.5
—
—
—
0
0
181
1689
1.55
1.32
23.1
14.4
75.94
80.65
ml/min/173m2
1.99
171
1578
6
24
2.54
1.31
1.3
1.2
—
—
—
0
0
6
24
2.54
1.31
1.3
1.2
—
—
—
0
0
8
34
2.41
1.30
1.1
1.4
—
—
—
0
0
5
18
2.82
1.29
1.6
1.1
—
—
—
0
0
5
18
2.82
1.29
1.6
1.1
—
—
—
0
0
5
18
2.82
1.29
1.4
1.2
—
—
—
0
0
179
1670
1.52
1.26
10.3
6.3
45.15
38.94
mmol/mol
7.33
169
1580
125
1100
1.34
1.26
3.6
3.2
—
—
—
0
0
6
25
2.44
1.25
1.0
1.5
—
—
—
0
0
5
19
2.67
1.22
1.6
1.1
—
—
—
0
0
5
19
2.67
1.22
1.6
1.4
—
—
—
0
0
5
19
2.67
1.22
1.6
1.1
—
—
—
0
0
56
441
1.37
1.16
2.5
2.2
—
—
—
0
0
10
51
2.01
1.13
1.0
3.0
1.40
2.01
ratio
—
5
26
10
51
2.01
1.13
1.0
1.2
—
54.38
—
0
8
10
52
1.97
1.08
1.1
1.2
—
—
—
0
0
36
266
1.43
1.08
4.5
3.0
2.49
3.15
e6/l
0.21
18
124
7
33
2.16
1.06
1.1
1.4
—
—
—
0
0
98
849
1.29
1.04
3.2
2.6
—
—
estimate
—
0
0
29
208
1.46
1.01
2.0
1.7
—
—
—
0
0
25
174
1.50
1.01
2.0
3.3
—
—
—
0
0
17
108
1.63
1.00
11.6
7.0
23.05
24.74
mmol/l
0.91
17
102
5
23
2.20
0.98
1.0
1.2
—
—
—
0
0
10
54
1.89
0.98
3.7
1.9
1.91
1.36
mg/l
—
10
47
9
50
1.84
0.98
1.2
1.2
—
—
—
0
0
8
42
1.94
0.89
3.7
1.5
136.50
125.87
g/l
—
8
31
15
96
1.61
0.87
3.7
4.4
1.02
1.02
ratio
0.05
15
88
55
452
1.29
0.85
4.9
4.1
1.02
1.02
kg/l
0.33
38
290
42
336
1.31
0.79
6.4
3.6
493.52
277.81
ng/l
0.23
33
250
6
34
1.79
0.77
1.5
1.3
—
—
—
0
0
5
24
2.11
0.75
1.4
1.2
—
—
—
0
0
5
26
1.95
0.71
1.4
1.1
—
—
—
0
0
22
164
1.38
0.65
1.3
2.0
—
—
—
0
0
17
121
1.44
0.64
11.2
7.1
92.94
94.11
%
0.38
17
121
5
29
1.74
0.64
1.8
1.3
—
—
—
0
0
5
29
1.74
0.64
1.8
1.3
—
—
—
0
0
16
113
1.45
0.63
4.2
2.5
1.27
1.14
%
0.38
16
113
8
49
1.66
0.63
4.1
4.0
22.05
32.74
mg/l
—
8
33
8
51
1.59
0.61
1.4
1.2
—
—
—
0
0
6
35
1.73
0.58
1.5
1.3
—
—
—
0
0
23
177
1.34
0.57
1.3
2.1
—
—
—
0
0
13
90
1.47
0.57
1.5
1.5
—
—
—
0
0
7
107
0.64
0.50
1.0
1.8
—
—
—
0
0
5
82
0.60
0.47
1.0
1.8
—
—
—
0
0
7
51
1.39
0.44
1.6
1.8
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
5
37
1.36
0.37
1.0
1.5
—
—
—
0
0
14
110
1.29
0.32
9.5
3.8
48.50
46.57
%
0.10
14
105
44
392
1.16
0.32
2.4
2.4
2.44
2.45
mmol/l
0.33
38
351
7
97
0.71
0.31
1.0
1.0
—
—
—
0
0
14
173
0.80
0.30
5.9
5.0
21.16
22.49
%
—
7
88
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
51.29
—
0
14
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
892.26
—
0
14
174
1708
1.11
0.19
6.3
5.0
6.63
5.86
mmol/l
3.88
160
1576
7
63
1.11
0.17
1.3
1.3
—
—
—
0
0
82
785
1.07
0.16
2.4
1.9
1.35
1.34
mmol/l
0.03
70
677
127
1235
1.07
0.16
4.5
3.0
73.09
42.15
u/l
1.60
121
1175
6
79
0.75
0.16
1.5
1.6
—
—
—
0
0
14
153
0.91
0.07
1.4
1.4
—
—
—
0
0
9
102
0.88
0.06
1.4
1.4
—
—
—
0
0
36
375
0.95
0.06
1.8
1.5
—
—
—
0
0
15
162
0.92
0.06
3.5
2.7
47.50
68.43
ml/min/173m2
—
10
70
19
200
0.94
0.04
6.5
7.2
—
—
—
0
0
168
1671
1.03
0.02
6.1
4.1
1.32
1.23
mmol/l
0.95
157
1548
175
1757
0.97
0.01
7.2
4.9
4.58
4.74
mmol/l
1.30
165
1644
178
1786
0.98
0.00
7.9
5.6
2.57
2.76
mmol/l
2.00
165
1664
175
1754
0.99
0.00
7.0
4.8
1.55
1.55
mmol/l
0.05
161
1633
0
8
0.00
0.00
0.0
1.0
—
14.88
—
0
8
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
6
63
0.95
-0.00
1.2
1.1
—
—
—
0
0
6
62
0.97
-0.00
1.3
1.8
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
44.30
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
13.73
—
0
7
6
63
0.95
-0.00
1.2
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_HYTHYPOSTINF and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_HYTHYPOSTINF | 1.889 [1.3, 2.75] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.278 |
During the follow-up period (1.1.1998 — 31.12.2019), 115 out of 430 females with E4_HYTHYPOSTINF died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have E4_HYTHYPOSTINF.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.184% | No data |
| 5 | 1.234% | No data |
| 10 | 2.848% | No data |
| 15 | 5.051% | No data |
| 20 | 9.149% | No data |
Relationships between endpoints
↥Index endpoint: E4_HYTHYPOSTINF – Postinfectious hypothyroidism
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data